Tracker App Reveals Six Types of COVID-19 Infection
|
By HospiMedica International staff writers Posted on 29 Jul 2020 |
|
Image: The COVID Symptom Study Smartphone application (Photo courtesy of Zoe Global)
A new study of data from a COVID-19 symptom-tracking app finds there are six distinct types of the disease, each with its own cluster of symptoms.
Researchers at King’s College London (KCL; United Kingdom), Lund University (Sweden), Massachusetts General Hospital (MGH; Boston, USA), and other institutions conducted a study that examined time series clustering of symptom presentation that was performed on data derived from a training dataset of completed cases, as collected from the COVID Symptom Study Smartphone application, developed by Zoe Global.
The study, which was published on June 12, 2020, in medRxiv, identified six types of COVID-19:
• 'Flu-like' with no fever: Headache, loss of smell, muscle pains, cough, sore throat, chest pain, no fever.
• 'Flu-like' with fever: Headache, loss of smell, cough, sore throat, hoarseness, fever, loss of appetite.
• Gastrointestinal: Headache, loss of smell, loss of appetite, diarrhea, sore throat, chest pain, no cough.
• Severe level one, fatigue: Headache, loss of smell, cough, fever, hoarseness, chest pain, fatigue.
• Severe level two, confusion: Headache, loss of smell, loss of appetite, cough, fever, hoarseness, sore throat, chest pain, fatigue, confusion, muscle pain.
• Severe level three, abdominal and respiratory: Headache, loss of smell, loss of appetite, cough, fever, hoarseness, sore throat, chest pain, fatigue, confusion, muscle pain, shortness of breath, diarrhea, abdominal pain.
“Patients with level four, five, and six types were more likely to be admitted to hospital and more likely to need respiratory support,” concluded co-lead author Claire Steves, MD, of KCL, and colleagues. “If you can predict who these people are at day five, you have time to give them support and early interventions such as monitoring blood oxygen and sugar levels, and ensuring they are properly hydrated.”
Besides cough, fever, and loss of smell, often highlighted as three key symptoms of COVID-19, app data showed others symptoms, including headaches, muscle pains, fatigue, diarrhea, confusion, loss of appetite, and shortness of breath.
Related Links:
King’s College London
Lund University
Massachusetts General Hospital
Zoe Global
Researchers at King’s College London (KCL; United Kingdom), Lund University (Sweden), Massachusetts General Hospital (MGH; Boston, USA), and other institutions conducted a study that examined time series clustering of symptom presentation that was performed on data derived from a training dataset of completed cases, as collected from the COVID Symptom Study Smartphone application, developed by Zoe Global.
The study, which was published on June 12, 2020, in medRxiv, identified six types of COVID-19:
• 'Flu-like' with no fever: Headache, loss of smell, muscle pains, cough, sore throat, chest pain, no fever.
• 'Flu-like' with fever: Headache, loss of smell, cough, sore throat, hoarseness, fever, loss of appetite.
• Gastrointestinal: Headache, loss of smell, loss of appetite, diarrhea, sore throat, chest pain, no cough.
• Severe level one, fatigue: Headache, loss of smell, cough, fever, hoarseness, chest pain, fatigue.
• Severe level two, confusion: Headache, loss of smell, loss of appetite, cough, fever, hoarseness, sore throat, chest pain, fatigue, confusion, muscle pain.
• Severe level three, abdominal and respiratory: Headache, loss of smell, loss of appetite, cough, fever, hoarseness, sore throat, chest pain, fatigue, confusion, muscle pain, shortness of breath, diarrhea, abdominal pain.
“Patients with level four, five, and six types were more likely to be admitted to hospital and more likely to need respiratory support,” concluded co-lead author Claire Steves, MD, of KCL, and colleagues. “If you can predict who these people are at day five, you have time to give them support and early interventions such as monitoring blood oxygen and sugar levels, and ensuring they are properly hydrated.”
Besides cough, fever, and loss of smell, often highlighted as three key symptoms of COVID-19, app data showed others symptoms, including headaches, muscle pains, fatigue, diarrhea, confusion, loss of appetite, and shortness of breath.
Related Links:
King’s College London
Lund University
Massachusetts General Hospital
Zoe Global
New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
New
Gas Analyzer
GE SAM
New
Digital Radiography System (Ceiling Free)
Digix CF Series
Latest AI News
- AI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
- Machine Learning Approach Enhances Liver Cancer Risk Stratification
- New AI Approach Monitors Brain Health Using Passive Wearable Data
- AI Tool Maps Early Risk Patterns in Bloodstream Infections
- AI Model Identifies Rare Endocrine Disorder from Hand Images
- AI Tool Promises to Reduce Length of Hospital Stays and Free Up Beds
Channels
Critical Care
view channel
Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
Hospitalizations for heart failure with preserved ejection fraction (HFpEF) remain common because lung congestion often worsens before symptoms prompt treatment changes. Missed early decompensation... Read more
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
Surgical Techniques
view channel
Ultrasound Technology Aims to Replace Invasive BPH Procedures
Benign prostatic hyperplasia (BPH) is a frequent cause of lower urinary tract symptoms in aging men and often requires invasive procedures or prolonged recovery. With prevalence expected to rise as populations... Read more
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
